What Diseases Can Pomegranate Cure?

What the Clinical Research Actually Confirms

My uncle was diagnosed with hypertension two years ago. He was fifty-three, not particularly overweight, not a smoker — just someone whose blood pressure had crept up quietly over years of a demanding job and an imperfect diet. His doctor started him on medication. And then my aunt, true to form, started loading his plate with pomegranate. Every morning. Every evening. Pomegranate arils, pomegranate juice, pomegranate over yoghurt. “It’s good for the blood,” she said. “It’s good for everything.” That phrase — “it’s good for everything” — is what finally made me sit down and actually look at the research. Because I wanted to know: what diseases can pomegranate cure — specifically, with actual clinical evidence behind the claim, not just inherited wisdom?

I spent several weeks going through PubMed, PMC, and review papers. I read meta-analyses, clinical trial summaries, and mechanistic studies. And what I found was more interesting — and more honest — than anything I had read in a health blog before. The question of whether pomegranate can help with diseases has a real, evidence-based answer. Some of it is genuinely impressive. Some of it is still preliminary. And some of the most confidently repeated claims barely hold up to scrutiny. Here is the full picture, graded honestly.

Why I Decided to Actually Read the Research

I have always been the person in my family who wants to see the source. Not because I distrust traditional food wisdom — I have genuine respect for the nutritional knowledge passed down through generations. But because I know that “good for everything” claims rarely survive contact with peer-reviewed evidence, and I did not want to be confidently wrong about something as important as my uncle’s cardiovascular health.

So I started from scratch. I looked for human clinical trials first — not animal studies, not cell-line experiments, not anecdote. And where human evidence was limited but the mechanistic case was strong, I said so clearly. The goal was not to prove or disprove pomegranate. It was to find out what the science actually says, at what level of confidence, and for which specific conditions.

What I found surprised me in both directions. The evidence for heart health was stronger than I expected. The cancer research was more preliminary than most health articles implied. And one finding — about oral health — I had never seen mentioned anywhere before.

An Honest Word About “Curing” Disease Before We Go Any Further

No single food cures disease. I want to say that plainly before going any further, because I think the framing matters enormously here. What foods — including pomegranate — can do is reduce risk, slow progression, improve biomarkers, and support the body’s own regulatory systems. That is genuinely valuable. But it is not the same as treatment, and it should not replace one.

A comprehensive 2024 review published in Cureus confirmed that randomised clinical trials have provided pharmacological evidence for pomegranate’s effects across diabetes, cardiovascular disease, oral health conditions, endocrine disorders, and cancer. The NIH’s National Centre for Complementary and Integrative Health notes the research quality is variable and many trials are small. Both of those things are true simultaneously.

I am going to present what the research says for each condition — and I am going to be honest about how strong that evidence actually is. That is more useful to you than a clean list of diseases followed by a footnote you will never read.

What Diseases Can Pomegranate Help? Seven Conditions With Clinical Evidence

1. Cardiovascular Disease — The Most Consistently Supported Finding

This is where the research is most convincing. A 2025 comprehensive review published in eFood (Wiley) confirmed that pomegranate reduces inflammation, improves endothelial function, and beneficially modulates blood lipids — three of the core mechanisms that drive cardiovascular disease. The fruit’s punicalagins reduce the oxidation of LDL cholesterol — the specific form of LDL most associated with arterial plaque formation.

A landmark study on patients with carotid artery stenosis found that daily pomegranate juice consumption slowed atherosclerosis progression and reduced arterial wall thickness over time. The study compared pomegranate to placebo over three years — and the pomegranate group showed measurable differences in plaque development. This is not a nutrient composition study. This is clinical evidence in people with actual arterial disease.

If you want to go deeper on the cholesterol side of this picture, I looked into the cholesterol question separately in detail — the findings are consistent with the broader cardiovascular evidence reviewed here.

Evidence strength: strong across multiple human trials. This is the most robust disease application in the pomegranate literature.

2. High Blood Pressure (Hypertension) — The Finding That Changed How I Think About My Uncle’s Diet

This is the one that made me call my aunt and tell her she was right — partially. A 2024 meta-analysis published in Phytotherapy Research found that pomegranate consumption produced significant reductions in both systolic and diastolic blood pressure across multiple randomised trials. Not by a trivial amount. Meaningfully.

The mechanism is one of the most clinically interesting findings in this whole area: pomegranate acts as a natural ACE inhibitor — blocking angiotensin-converting enzyme, which is the same target as prescribed antihypertensive drugs like lisinopril. The fruit does this through a different, gentler pathway — but the mechanism is real, documented, and pharmacologically meaningful.

💡 The ACE inhibitor connection:

Pomegranate inhibits angiotensin-converting enzyme (ACE) — the same enzyme targeted by a class of blood pressure medications. This does not mean it replaces prescribed treatment. But the mechanism is genuinely pharmacological, not just “antioxidants are good for you.” For people with borderline hypertension, this finding deserves attention.

My uncle continues his medication. But he also eats pomegranate every day now — and his last two blood pressure readings were the best they had been in four years. I cannot attribute that solely to pomegranate. But I am not dismissing it either.

3. Type 2 Diabetes — Promising Evidence With Important Caveats

A 2024 systematic review and meta-analysis in Diabetes & Metabolic Syndrome (Bahari et al.) examined pomegranate’s effects on glycaemic indices in adults across multiple trials. The findings showed improvements in insulin sensitivity and reductions in fasting blood glucose in some groups. The proposed mechanism: punicalagins and ellagic acid inhibit alpha-glucosidase — an enzyme that accelerates the conversion of starch to glucose — which slows post-meal blood sugar spikes.

The honest caveat here is important: trials are mixed. Some showed significant effects; others showed none. Results appear more consistent for pomegranate extract and juice than for whole fruit consumption. And because pomegranate contains natural sugars — around 14g per 100g of arils — large amounts of juice can raise blood glucose in sensitive individuals. For diabetics, portion control and whole-fruit preference matter significantly.

Evidence strength: promising meta-analysis data; inconsistent across individual trials; real mechanism but not yet definitive.

4. Prostate Cancer — The Most Studied Oncology Application

Pomegranate is the most extensively studied fruit in prostate cancer research, and this area has the most compelling human data outside of cardiovascular disease. A landmark clinical trial found that men with recurrent prostate cancer who drank 240ml of pomegranate juice daily increased their median PSA doubling time — the rate at which prostate-specific antigen levels rise — from 15 months to 54 months. PSA doubling time is used as a marker of cancer progression. Slowing it from 15 to 54 months is a clinically meaningful finding.

A 2025 review in Food Science & Nutrition (Rauf et al.) confirmed pomegranate extracts show anti-proliferative and anti-tumorigenic properties in prostate, breast, bladder, lung, and colon cancer cell models. The compounds responsible include ellagic acid, punicalagins, and luteolin, which modulate signalling pathways involved in inflammation and tumour progression.

The honest caveat: most cancer research beyond the prostate PSA study is in cell lines and animal models. Cell-line results do not automatically translate to clinical outcomes in humans. This research is genuinely exciting — and it is genuinely preliminary. Anyone with a cancer diagnosis should follow their oncologist’s guidance, not a dietary blog.

Evidence strength: strongest in prostate cancer (human PSA trial); promising but not clinically confirmed in breast, lung, colon, and bladder.

5. Arthritis and Chronic Inflammatory Disease

Pomegranate’s most universal therapeutic mechanism is its anti-inflammatory action. The fruit’s punicalagins inhibit the production of key inflammatory cytokines — including TNF-α, IL-1β, and IL-6 — by blocking the NF-κB signalling pathway. This pathway is central to the development and persistence of rheumatoid arthritis, inflammatory bowel disease (IBD), and other chronic inflammatory conditions.

Research from the University of Huddersfield found that punicalagin could reduce the painful neuroinflammation associated with Parkinson’s disease and rheumatoid arthritis, and scientists were actively developing punicalagin derivatives for anti-inflammatory drug applications. A PMC review confirmed strong evidence in animal models for IBD — and a small number of human trials that show directional benefit.

Evidence strength: mechanistic evidence is among the strongest in the pomegranate literature; human clinical trial data for specific inflammatory diseases is still limited but growing.

6. Alzheimer’s Disease — The Most Exciting 2024 Finding

In May 2024, researchers at the University of Copenhagen published findings showing that urolithin A — a compound produced when gut bacteria metabolise pomegranate’s ellagitannins — can alleviate memory problems and cognitive decline in Alzheimer’s mouse models. Urolithin A supports mitophagy — the cellular cleaning process that clears damaged mitochondria — which is significantly impaired in Alzheimer’s disease.

Separately, punicalagin’s neuroinflammatory effects were confirmed to slow the progression of Alzheimer’s symptoms in animal models by the University of Huddersfield research team. A PMC review in 2022 confirmed that pomegranate may be valuable in treating neurodegenerative disorders including Alzheimer’s and Parkinson’s disease, while explicitly noting that human clinical trial data is still lacking.

Evidence strength: genuinely exciting mechanistic and animal model data from 2024; human clinical trials have not yet been conducted at scale. This is the most watched area for future pomegranate research.

7. Oral Health — The Finding Nobody Is Talking About

This surprised me most. Of all the disease categories I investigated, oral health had some of the most consistently supported human clinical evidence — and it is almost never discussed in mainstream pomegranate content.

Multiple human trials have documented pomegranate’s benefits for dental plaque reduction, gingivitis (gum inflammation), and oral bacteria counts. The antimicrobial polyphenols in pomegranate juice — particularly ellagitannins and anthocyanins — inhibit the growth of Streptococcus mutans, the primary bacterium behind tooth decay. The 2024 Cureus review confirmed oral cavity disorders as one of the most consistently validated clinical applications of pomegranate.

🌿 The underreported finding:

Oral health is one of pomegranate’s best-supported clinical applications — and almost no health blog mentions it. Regular pomegranate juice use (consumed or used as a rinse) has measurable effects on gum inflammation and pathogenic oral bacteria. If you are looking for evidence-based reasons to add pomegranate to your daily routine, this is one of the cleanest ones.

What the Research Does NOT Support — Being Honest About the Gaps

I want to be clear about what the evidence does not confirm, because I think that honesty is what separates genuinely useful health content from cheerleading.

• Pomegranate cannot treat active cancer. The oncology research — outside the prostate PSA study — is in cell lines and animal models. Promising and worth watching; not clinically confirmed.
• The cardiovascular and diabetes evidence involves small trials. Direction is consistent; scale of evidence is not yet definitive.
• Most inflammatory disease data comes from animal models. Mechanistic plausibility is real. Clinical confirmation in humans is still building.
• The NIH NCCIH states plainly that “the limited research that has been completed does not allow conclusions to be reached about whether pomegranate is helpful for most health conditions” beyond the most studied areas. That is a fair summary of where the evidence actually sits.

My honest position after weeks of reading: the strongest human evidence is in cardiovascular health, blood pressure reduction, and oral health. The cancer, Alzheimer’s, and arthritis research is genuine and exciting — and it is preliminary. Both things are true, and pretending otherwise does not serve the reader.

How I Now Think About Pomegranate as a Disease-Prevention Food

After all this research, I did not become someone who believes pomegranate is medicine. I became someone who eats it with purpose rather than habit.

The cardiovascular and blood pressure evidence is strong enough that I treat pomegranate as a deliberate part of my heart-health diet. I eat 80 to 100 grams of arils with lunch most days — specifically on days when I am eating other anti-inflammatory foods like olive oil, oily fish, or leafy greens. I think of it as one component of a nutritional strategy, not the whole strategy.

When I want the more concentrated polyphenol benefit — particularly for the blood pressure evidence — I have 100 to 150ml of natural, unsweetened pomegranate juice with my main meal. Not the commercial versions with added sugar.

I think about it as a disease-prevention food rather than a treatment. Prevention and treatment are different things, and conflating them is where health content goes wrong. The evidence supports pomegranate for prevention and risk reduction. For treatment, you need your GP.

And beyond the disease angle, its effect on blood health goes deeper than most people realise — its effect on blood health goes deeper than most people realise, including a documented clinical effect on haemoglobin and red blood cell count that I wrote about separately.

For those specifically concerned about blood cell production, including a documented effect on platelet levels is also worth understanding — particularly for anyone recovering from a viral illness or managing a blood condition.

One practical note if you are increasing your daily intake for therapeutic reasons: larger amounts can sometimes cause digestive side effects worth being aware of — knowing this in advance means you can adjust your portion rather than abandon the fruit entirely.

On timing, timing your pomegranate consumption thoughtfully — particularly pairing it with meals rather than eating it alone — makes a real difference to how your body processes its compounds.

My Honest Final Answer

After weeks of reading basic research, this is something I would say to anyone who asks me what diseases pomegranate can help.

Human clinical trials have the strongest evidence for heart disease, hypertension, and oral health.  These are areas where I would feel confident that pomegranate has a real, evidence-based role in disease prevention and risk reduction. The effect of ACE inhibitors on blood pressure and reduction of LDL oxidation is particularly well documented.

The evidence for type 2 diabetes, prostate cancer, arthritis and Alzheimer’s disease is promising but inconclusive. This mechanical casing is solid in all four. Human medical evidence is growing, but it is incomplete. These are areas to watch — and where regularly consuming pomegranate as an anti-inflammatory food is  a sensible, low-risk, evidence-based option.

Research does not support the idea that pomegranate treats functional diseases or is a substitute for medical treatment. It’s a diet — an exceptionally researched, nutritionally impressive diet with real healing properties — but it’s still a diet.

My aunt wasn’t wrong with the grenades. I just couldn’t explain why. Now I can do it.

Frequently Asked Questions

⚕️ Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Pomegranate is a food, not a medical treatment. If you have a diagnosed health condition, always consult a qualified healthcare professional before making dietary changes intended to support your treatment.

Faizan Ahmed

“I am a health content writer who started this journey the same way many readers arrive here — searching for clear, honest answers at the wrong hour, and finding content that was either too complicated or too vague to help. Pure Vitality Tips was built out of that experience. Every article published here is researched first — drawing from peer-reviewed studies, WHO, CDC, NHS, NIH, and leading clinical journals. I am not a doctor, but I take the responsibility of writing about health seriously — because I know first-hand how much accurate information matters.”